Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review.
Aisha A MumtazAndrew FischerForat LutfiLisa R MatsumotoDjordje AtanackovicElif T KolanciKim G HankeyNancy M HardyJean A YaredMehmet H KocogluAaron P RapoportSaurabh DahiyaAlbert S LiSarah Brem SunshinePublished in: The British journal of ophthalmology (2022)
The increasing use of CAR T therapy for malignancies underscores the importance of ophthalmologists and oncologists understanding the potential toxicities associated with its use, particularly ocular toxicities and when to refer for an ophthalmic examination.